Signet Therapeutics, a clinical-stage biotech company leveraging organoid- and AI-driven cancer drug discovery, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...

Source: Sino Biological Inc. Organoid platforms, together with cytokine-driven differentiation protocols, enable high-throughput drug screening. For example, liver organoids supported by VEGF and ...

BOSTON & SHENZHEN, China--(BUSINESS WIRE)--Signet Therapeutics, a clinical-stage biotech company leveraging organoid- and AI-driven cancer drug discovery, announced that the U.S. Food and Drug ...

The effect of circadian rhythm–based medication timing adjustments on the efficacy and safety of novel hormonal therapy. Phase III, double-blind, placebo-controlled, 2-cohort, randomized study of ...

Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...

A key highlight of Okomera's presence at SLAS 2025 will be the presentation of their poster titled "End-to-End Automated Organoid Screening Platform: Application in Breast Cancer Drug Screening".

The HUMANOID Center at UC San Diego is pioneering organoid research aimed at improving the reliability and reproducibility of ...

Italy Organoids and Spheroids Market Research Report The Italy organoids and spheroids market is projected to reach $36.6 million by 2032, ...

Google has unveiled an AI co-scientist built on its Gemini 2.0 platform, aiming to accelerate scientific research by ...

Scientists from the German Cancer Research Center (DKFZ) and ShanghaiTech University have developed an innovative method for ...